Next Generation Probiotics

From Novel Drugs to Future Therapeutics
1. Auflage 2025
ISBN: 978-1-032-51638-7
Verlag: Taylor & Francis Ltd

Buch, Englisch, 296 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 453 g

Reihe: Current Developments in Agricultural Biotechnology and Food Security

Next Generation Probiotics: From Novel Drugs to Future Therapeutics provides a comprehensive and cutting-edge exploration of probiotics as powerful therapeutic agents. With the rapid advancements in the field, this book offers a deep dive into how probiotics are evolving beyond traditional uses, addressing complex health conditions and diseases in modern medicine. By combining the latest scientific research with practical applications, this book equips researchers, clinicians, and healthcare professionals with the knowledge needed to incorporate probiotics into clinical practice and future therapeutic strategies.

The book covers a wide range of essential topics, including:

- Probiotic mechanisms and the chemical characterization of bioactive compounds derived from probiotics

- The emerging role of probiotics in gut-brain interactions and psychobiotics for mental health

- Probiotic-based drug development and their applications in personalized medicine

- Probiotics in the prevention and treatment of gastrointestinal disorders, metabolic diseases, and cancer

- The integration of next-generation sequencing and machine learning in optimizing probiotic therapies

- Probiotics in functional foods and their potential to alleviate lactose intolerance

- Applications in animal health, focusing on terrestrial and aquatic animals

This book stands out by offering an exhaustive examination of probiotics in therapeutic applications, providing real-world examples and insights into how these microorganisms are reshaping modern medicine. Next Generation Probiotics is a must-read for researchers, clinicians, and healthcare professionals interested in the future of probiotics as a therapeutic tool for a wide range of health challenges.

Zielgruppe

Professional Reference

Autoren/Hrsg.

Di Cerbo, Alessandro

Ghazanfar, Shakira

Adetunji, Charles Oluwaseun

Muhammad Ali, Ghulam

Naeem Riaz, Muhammad

Ajmal, Wajya

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften
• Naturwissenschaften Biowissenschaften Mikrobiologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Lebensmitteltechnologie und Getränketechnologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie Medizinische Biotechnologie

Inhaltsverzeichnis

Contents

1. Probiotics: Introduction, Brief History and Benefits

2. Chemical Characterization of Active Compounds Derived from Probiotic Microorganisms

3. Relevant Patents, Social Economic Aspects and Market Share and Process Involved in the Commercialisation and Industrialization of Probiotics

4. The Protective Potential Role of Probiotics against Stress Risks in Livestock

5. Indigenous Developed Probiotic Products: A Promising Approach to Improve Health and Production

6. Probiotic: Mode of Action and its Application in Small Ruminants

7. Target-Based Probiotic: Linking the Gut Microbiota with Health and Disease

8. Probiotic Cultures in Functional Dairy Products

9. Probiotic Potential of Mangifera indica for the Alleviation of Lactose Intolerance

10.The Identification and Application of High Potential Probiotics in the Age of Next Generation Sequencing (NGS)

11.The Roles of the Human Microbiome in the Gastrointestinal Tract in Relation to Probiotics in the Management of Gastric Cancer and Other Related Diseases

12.Recent Advances in the Application of Machine Learning in Development of Probiotics

13.Gut-Brain Axis and Role of Probiotics

14.Techniques Involved in the Isolation of Microbiome in the Gut as a Potential Probiotics

15.Psychobiotics: A Microbe-Mediated Biotherapeutic for Mental Health

16.Role of Probiotics to Control the Gut-Related Diseases in Terrestrial and Aquatic Animals

17.The Role of Translational Research in the Development of Products Using Probiotics for Wealth Creation

18.Relevant Information on Consumer’s Perspective and Diverse Sensory Evaluation of Numerous Dairy Products Using Probiotics

19.Comparative Use of Bacteriotherapy in Human and Animal Gut Health

Über Autor(innen)

Prof Charles Oluwaseun Adetunji

Prof Charles Oluwaseun Adetunji is presently a faculty member at the Microbiology Department, Faculty of Science, Edo State University Uzairue, Edo State, Nigeria, where he utilized the application of biological techniques and microbial bioprocesses for the actualization of sustainable development goals and agrarian revolution, through quality teaching, research, and community development. He was formally the Acting Director of Intellectual Property and Technology Transfer, the Head of the Department of Microbiology, Sub Dean of the Faculty of Science, and currently the Chairman Grant Committee and immediate Dean of Faculty of Science, and now the Director of Research and Innovation at EDSU.

Dr. Shakira Ghazanfar

Dr. Shakira Ghazanfar is working as Senior Scientific Officer at PARC, Islamabad, Pakistan since 2007. She did her Ph.D in Microbiology from Quaid-i-Azam University Islamabad Pakistan. Her area of research is development and commercialization of the TARGET BASED Probiotic Products based on AI/DL/ML. She is regarded among the pioneers, who have initiated Animal Probiotic Research to improve livestock productivity in Pakistan. She is the Main Organizer (100 plus training organizer) of the Training/Workshops/Webinars in her Department. Published more than 100+ research papers (400 plus impact factor), 50+ book chapters, and Main editor of CRC press USA and Springer Nature publishers' books. She is Guest Editor in well-known Journals. She co/supervised/supervising research of 20+ PhD, 100+ MPhil/BS students. She has published widely in the field of AI/ML/DL and food microbiology, drug discovery, nutraceuticals and functional foods with specialization in probiotics-based food/feed and probiotic related anticancer agents.

Alessandro Di Cerbo

Professor Alessandro Di Cerbo, BSc, MSc, PhD, PD, is an Associate Professor of Veterinary Pharmacology and Toxicology at the University of Camerino, Italy, School of Biosciences and Veterinary Science. He has published 133 peer-reviewed papers (h-index: Google Scholar 30, Scopus 27) with 2,789 Google Scholar and 2,088 Scopus citations, edited one monograph, and authored four book chapters. Eligible to serve as a Full Professor since January 2022 and an Associate Professor since November 2020 (Italian Ministry of Education, University, and Research), he is an editorial board member or Associate Editor for several prominent journals, including Frontiers in Veterinary Science and BMC Veterinary Research. His research interests focus on pharmacological residues in animal-derived foods, animal well-being, nutraceutical efficacy, toxicological evaluations, antimicrobial activity of natural products, and nanotechnology applications in food and drugs.

Ghulam Muhammad Ali

Dr. Ghulam Muhammad Ali, Chairman of the Pakistan Agricultural Research Council (PARC), is a distinguished scientist in molecular biology and biotechnology with a PhD from the University of Liverpool and postdoctoral fellowships from Canada and Japan. He has held pivotal roles at PARC, including Director General of NARC and Member of Plant Sciences Division. Dr. Ali has published around 400 papers, led numerous research projects, and established the National Institute for Genomics and Advanced Biotechnology (NIGAB). He pioneered innovations like aeroponic potato seed production, virus-free banana varieties, and Green Super Rice development. Recognized with multiple awards, Dr. Ali’s groundbreaking work in crop improvement and food security underscores his impactful career.

Wajya Ajmal

Wajya Ajmal is an accomplished bioinformatics professional, who serves as a Scientific Officer at the National Institute for Genomics and Advanced Biotechnology (NIGAB), Islamabad, Pakistan, a role held since April 2022. With over eight years of experience in the biotechnology industry, including prior work as an Assistant Scientific Officer at NIGAB, she possess expertise in sequence analysis, bioinformatics, Python, systems biology, and Perl. A strong research background supports their work, including a Master of Philosophy (MPhil) in Bioinformatics from Quaid-i-Azam University (2012–2014) and a Bachelor of Science (BS) in Bioinformatics from COMSATS University Islamabad (2007–2011). Wajya’s career reflects a robust commitment to advancing genomics and biotechnology through innovative research and technical proficiency.

Muhammad Naeem Riaz

Naeem Riaz is the Head of the National Institute for Genomics and Advanced Biotechnology (NIGAB) at the Pakistan Agricultural Research Council (PARC), Islamabad. A seasoned expert in molecular biology, biotechnology, and genomics, he has made significant contributions to agricultural research and innovation. With extensive experience in genomics, bioinformatics, and molecular techniques, Naeem has led pioneering research projects and spearheaded the development of advanced biotechnological solutions to enhance crop productivity and food security. Under his leadership, NIGAB has emerged as a leading biotech center, fostering innovation and training skilled researchers. Naeem Riaz's dedication to advancing biotechnology continues to drive impactful contributions to Pakistan's agricultural sector.